[68Ga]Ga-DOTA.SA.FAPi与[68Ga]Ga-DOTANOC正电子发射断层扫描/计算机断层扫描成像在甲状腺髓样癌患者随访监测中的头对头比较
本研究回顾性比较了[68Ga]Ga-DOTA.SA.FAPi与[68Ga]Ga-DOTANOC PET/CT在27例甲状腺髓样癌患者随访中对原发及转移灶的检测效能。结果显示两者对原发肿瘤、受累淋巴结和脑转移的敏感性相似,但[68Ga]Ga-DOTA.SA.FAPi对肺结节、肝、骨和胸膜转移的敏感性显著更高,且摄取值和靶本比更高。
要点
- [68Ga]Ga-DOTA.SA.FAPi对肺结节、肝、骨和胸膜转移的敏感性显著高于[68Ga]Ga-DOTANOC PET/CT。
- 两者对原发肿瘤、受累淋巴结和脑转移的敏感性无显著差异。
- [68Ga]Ga-DOTA.SA.FAPi的摄取值和靶本比高于[68Ga]Ga-DOTANOC。
核心结论
- 在甲状腺髓样癌患者中,基于患者和病灶分析,[68Ga]Ga-DOTA.SA.FAPi PET/CT在检测远处转移方面优于[68Ga]Ga-DOTANOC PET/CT。
研究设计与样本
- 回顾性研究,纳入27例甲状腺髓样癌患者(21例男性,6例女性),平均年龄42.4 ± 13.2岁(范围14-66岁),比较[68Ga]Ga-DOTANOC与[68Ga]Ga-DOTA.SA.FAPi PET/CT图像,采用基于患者和基于病灶的分析,定量评估包括瘦体重校正的标准摄取值(SULpeak)和靶本比(TBR),并以诊断CT的形态学发现验证。
主要发现
- [68Ga]Ga-DOTA.SA.FAPi与[68Ga]Ga-DOTANOC PET/CT检测原发肿瘤的敏感性分别为100%(18/18)与94.4%(17/18),p=0.979。
- 检测受累淋巴结的敏感性分别为98.3%(118/120)与95%(114/120),p=0.288。
- 检测脑转移的敏感性均为100%。
- 检测肺结节的敏感性分别为93.5%(87/93)与68.9%(64/93),p<0.0001;检测肝转移分别为100%(105/105)与46.4%(49/105),p<0.0001;检测骨转移分别为92.4%(110/119)与76.5%(91/119),p=0.001;检测胸膜转移分别为98.2%与0%。
- [68Ga]Ga-DOTA.SA.FAPi的摄取值和靶本比高于[68Ga]Ga-DOTANOC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: A theranostic probe for accurate staging and treatment is crucial for the management of medullary thyroid cancers (MTCs). The abundance of stroma in most of thyroid cancers, including MTC, opens new avenues for selecting cancer-associated fibroblasts (CAFs) as new molecular imaging and therapeutic targets. [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPi) molecules have gained importance as alternative molecular imaging agents in the imaging of thyroid cancers. The purpose of this study was to compare the detection efficiency of primary and metastatic lesions of MTCs between [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC positron emission tomography (PET) radiotracers. Materials and Methods: In this retrospective study, [68Ga]Ga-DOTANOC and [68Ga]Ga-DOTA.SA.FAPi PET/CT (computed tomography) images were compared using patient-based and lesion-based analysis in patients with MTC for follow-up assessment. The quantitative assessment included comparing standardized uptake values corrected for lean body mass (SULpeak) and tumor-to-background ratios (TBR). The findings on both scans were validated with the morphological findings of the diagnostic CT. Results: Twenty-seven patients (21 males and 6 females) with a mean age of 42.4 ± 13.2 years (range 14-66 years) were included in the study. [68Ga]Ga-DOTA.SA.FAPi had similar sensitivities as that of [68Ga]Ga-DOTANOC PET/CT for detecting primary tumors (100% [18 of 18] vs. 94.4% [17 of 18], p = 0.979) involved lymph nodes (98.3% [118 of 120] vs. 95% [114 of 120], p = 0.288), and brain metastases (100%). [68Ga]Ga-DOTA.SA.FAPi demonstrated significantly higher sensitivities than [68Ga]Ga-DOTANOC PET/CT for detecting lung nodules (93.5% [87 of 93] vs. 68.9% [64 of 93], p < 0.0001), liver (100% [105 of 105] vs. 46.4% [49 of 105], p < 0.0001), bone (92.4% [110 of 119] vs. 76.5% [91 of 119], p = 0.001), and pleural metastases 98.2% versus 0%. Higher uptake values and TBR values were reported with [68Ga]Ga-DOTA.SA.FAPi compared with that of [68Ga]Ga-DOTANOC. Conclusion: [68Ga]Ga-DOTA.SA.FAPi outperformed [68Ga]Ga-DOTANOC PET/CT in the detection of distant metastases with both patient-based and lesion-based analysis in MTCs.
引用
- Ballal S, Yadav MP, Roesch F, et al. Head-to-Head Comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer. Thyroid. 2023. PMID: 37171126. doi:10.1089/thy.2023.0008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。